Reports: National Oncology Institute (Slovakia): Difference between revisions
No edit summary |
m (Update categories.) |
||
| Line 110: | Line 110: | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | ||
<span style="display:none">isReport</span> | <span style="display:none">isReport</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | |||
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span> | |||
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | |||
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span> | |||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | |||
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | |||
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> | |||
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | |||
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span> | |||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | |||
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | |||
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> | |||
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span> | |||
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> | |||
<span style="display:none">hasCancerType::unknown</span> | |||
Revision as of 11:29, 6 December 2025
Go back to Slovakia page
Primary purpose: To function as a clinical-research, academic, and educational platform to support the National Oncology Program in various areas, including epidemiology, science, research, prevention, screening, diagnosis, treatment, and supportive care.
Sponsor, manager or home institution: Národný Onkologický Inštitútu.
Type of information: Common cancers and cancer diseases; Overview and capacity of palliative care services; Availability and effectiveness of oncology treatments; Cost-effectiveness and participation in colorectal cancer screening; Number and participation rates of screenings for breast, cervical, colorectal, and lung cancers; Clinical stages and percentages of malignant tumours; Verified screening mammography facilities and participation rates and Number of women invited to mammography screenings and diagnosed malignancies. Click here to learn more.
Data level: national level and regional level.
Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.
Access to information: For annual reports click here to access. For screenings information click here to access; For epidemiological report of cancer diseases click here to access.